November 20th 2024
PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels were linked to worse outcomes.
November 20th 2024
November 20th 2024
November 19th 2024
November 18th 2024
November 14th 2024
November 17th 2024
October 27th 2024
October 23rd 2024
October 13th 2024
November 16th 2024
October 26th 2024
October 14th 2024